E. Saigí

发表

Extravasation of oxaliplatin: an infrequent and irritant toxicity

Joan Ramon Soler, C. Pericay, T. Bonfill, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

The Changing Pattern of Non-Small Cell Lung Cancer Between the 90th and 2000th Decades

X. Bonfill, E. Dalmau, M. Nogué, 2011, The open respiratory medicine journal.

Synchronous isolated adrenal metastasis from rectum adenocarcinoma

Á. Casalots, C. Pericay, A. Darnell, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Borage consumption as a possible gastric cancer protective factor.

E. Riboli, A. Agudo, C. González, 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status

M. A. Seguí, Á. Arcusa, F. Casas, 2012, Clinical and Translational Oncology.

Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer.

I. Tusquets, Á. Arcusa, L. Cirera, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gastrointestinal stromal tumors

E. Musulen, E. Dalmau, C. Pericay, 2006, Abdominal Imaging.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Irene Moya, Á. Casalots, C. Pericay, 2013, Oncology reports.

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

K. Roszkowski, M. Krzakowski, A. Parisi, 2000, Lung cancer.

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia.

A. Salar, A. González, A. Alegre, 2008, Current medical research and opinion.

Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing

N. Baena, G. Llort, A. Ruiz, 2014, BioMed research international.

Further evidence for preoperative chemoradiotherapy and transanal endoscopic surgery (TEM) in T2-3s,N0,M0 rectal cancer

Á. Casalots, C. Pericay, L. Mora-López, 2016, Clinical and Translational Oncology.

Consumption of alcohol, coffee, and tobacco, and gastric cancer in Spain

C. González, A. Agudo, J. Ortego, 1992, Cancer Causes & Control.

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer d

S. Polo, J. Aparicio, J. Maurel, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carboplatin-Gemcitabine Treatment of Patients with Transitional Cell Carcinoma of the Bladder and Impaired Renal Function

J. Carles, M. Doménech, R. Ibeas, 2000, Oncology.

Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.

Á. Arcusa, L. Cirera, P. Escudero, 2005, European journal of cancer.

Protracted treatment with tegafur and low dose oral leucovorin in patients with advanced colorectal carcinoma

Á. Arcusa, M. Nogué, M. Boleda, 1998, Cancer.

Dietary factors and stomach cancer in Spain: A multi‐centre case‐control study

E. Riboli, C. González, S. Pita, 1991, International journal of cancer.

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A gemcad study

J. Maurel, C. Pericay, A. Barnadas, 2013, Investigational New Drugs.

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

M. Salgado, V. Alonso, M. Méndez, 2014, BMC Cancer.

Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factors

Á. Arcusa, H. Manzano, F. Losa, 2004, Anti-cancer drugs.

Analysis of the pathologic response to primary chemotherapy in patients with locally advanced breast cancer grouped according to estrogen receptor, progesterone receptor, and HER2 status.

E. Gallardo, E. Dalmau, L. Fernández-Morales, 2007, Clinical breast cancer.

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

A. González, A. Alegre, J. Mel, 2008 .

Role of chemoradiotherapy alone in the management of unfit patients with nonmetastatic locally advanced squamous cell carcinoma of the esophagus.

C. Pericay, S. Navarro, A. Alvarado, 2011, Journal of Clinical Oncology.

[Ectopic ACTH secretion syndrome in a sigmoid neoplasia: an infrequent association].

J. Ordi, Á. Ruibal, J. Bosch, 1981, Revista clinica espanola.